CrushSCI.com
262.7平均天数
258中位天数
71最短天数
529最长天数
1712025发文量

Paper Review Records

全部论文审稿周期

15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

529 天

Systemic delivery of phagocytosis-shielded retroviral vectors enables in vivo HSC gene therapy for sickle cell disease

作者
Denise Klatt; Adele Mucci; Boya Liu; Marie Peschers; Giulia Schiroli; Axel Schambach; John Manis; Myriam Armant; David T. Scadden; Els Verhoeyen; Danilo Pellin; David A. Williams; Christian Brendel展开收起
作者单位
Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA 02115, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany; Department of Laboratory Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA; Therapeutic Innovation Lab, Boston Children’s Hospital, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; CIRI – International Center for Infectiology Research, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, 69007, Lyon, France; Université Côte d'Azur, Centre Méditerranéen de Médecine Moléculaire, Nice, France展开收起
PDF源文件 DOI 网页
264 天

H3K27M drives OPC stemness and intrathecal therapeutic vulnerability in brainstem glioma organoids

作者
Luyang Xie; Zhuang Jiang; Hang Zhou; Xiaoxue Zhu; Yibo Geng; Mingxin Zhang; Tengxian Guo; Ge Shen; Xiaoyan Li; Ligong Chen; Gairong Zhang; Changwen Xue; Tuozhang Li; Xixi Zheng; Yaqi Wang; Haitao Fu; Yuxuan Deng; Jingfeng Li; Kai Jiang; Wenhao Wu; Peng Zhang; Changcun Pan; Shaobo Shan; Yujie Tang; Huan Li; Liang Wang; Zhen Wu; Cheng Xu; Liwei Zhang展开收起
作者单位
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; Chinese Institutes for Medical Research, Beijing 100070, China; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China; Department of Neurosurgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; Department of Neurosurgery, Beijing Fengtai Hospital, Beijing 100070, China; Department of Radiotherapy and Oncology, Beijing Fengtai Youanmen Hospital, Beijing 100068, China; Department of Oncology, Beijing Huian Hospital of Integrated TCM and Western Medicine, Beijing 100068, China; Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100700, China; State Key Laboratory of Membrane Biology, School of Pharmaceutical Sciences, Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology (Ministry of Education), Tsinghua University, Beijing 100084, China; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China; Department of Paediatrics and Adolescent Medicine, The Hong Kong Children’s Hospital, Hong Kong 999077, China; Beijing WellGene Biotech Co., Ltd., Beijing 102200, China; Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Shanghai Key Laboratory of Reproductive Medicine, Department of Histoembryology, Genetics and Developmental Biology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; China National Clinical Research Center for Neurological Diseases, Beijing 100070, China; Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China展开收起
PDF源文件 DOI 网页
71 天

Clinical base editing for β-hemoglobinopathies across different genetic backgrounds

作者
Rongrong Liu; Yongrong Lai; Lijie Wang; Xiaowen Qian; Xu-Kai Ma; Yaliang Li; Gaohui Yang; Lingling Shi; Zifeng Li; Jia Wei; Zhenbin Wei; Hongsheng Wang; Xuemei Zhou; Ling Yu; Bei Yang; Xiaowen Zhai; Xiaodun Mou; Li Yang; Jia Chen展开收起
作者单位
Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, China; NHC Key Laboratory of Thalassemia Medicine, Nanning 530021, Guangxi, China; Guangxi Key laboratory of Thalassemia Research, Nanning 530021, Guangxi, China; Gene Editing Center, School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; CorrectSequence Therapeutics, Shanghai 201210, China; Department of Hematology and Oncology, Children’s Hospital of Fudan University, Shanghai 201102, China; Center for Molecular Medicine, Children’s Hospital of Fudan University and Shanghai Key Laboratory of Medical Epigenetics, International Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Shanghai Key Laboratory of Gene Editing and Cell Therapy for Rare Diseases, Fudan University, Shanghai 200032, China; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China; Shanghai Clinical Research and Trial Center, Shanghai 201210, China; Shanghai Academy of Natural Sciences (SANS), ShanghaiTech University, Shanghai 201210, China展开收起
PDF源文件 DOI 网页
163 天

Epi-Allele elicits compensatory expression of the non-targeted allele and prevents haploinsufficiency in dominant genetic diseases

作者
Zhengmin Wang; Chengzhi Han; Yiming Huang; Yuyuan Fu; Kaijie Hu; Zheyong Huang; Weiying Meng; Qiyao Chen; Leilei Wu; Qiaozi Wang; Jinyan Zhang; Hao Luo; Yifan Wang; Lulu Zuo; Yingqi Li; Yiwen Tan; Qin Zhou; Shaoshuai Mao; Wenbo Peng; Juan Meng; Maoxiang Chen; Zhiyang Tian; Shuwei Chen; Zihan Hu; Lu Zhao; Yihan Shen; Shanshan Chen; Zhixin Shen; Lijuan Mo; Jinfeng Gao; Qiyu Li; Shiteng Cai; Jianhuang Xue; Yanan Song; Yidi Sun; Junbo Ge; Changyang Zhou展开收起
作者单位
Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200031, China; Institute of Neuroscience, State Key Laboratory of Genetic Evolution & Animal Models, CAS Center for Excellence in Brain Science and Intelligence Technology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China; State Key Laboratory of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200031, China; Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Tongji Hospital affiliated to Tongji University, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China; Epigenic Therapeutics, Inc., Shanghai 201315, China; Shanghai Key Laboratory of Precision Gene Editing and Clinical Translation, Shanghai 200031, China展开收起
PDF源文件 DOI 网页
283 天

Engineered human iPSC-derived dendritic cells dressed with tumor MHC complexes as a cancer vaccine

作者
Huaigeng Xu; Chisato Kamei; Deniz Gökbuget; Jacob Du; Mercedes Barrero; Li Wang; Yoshihiro Iwamoto; Jason Mark Soriano; Krystal Godding; Bo Wang; Serena S. Kwek; Gabriel I. Nistor; Hans S. Keirstead; Lawrence Fong; Shin Kaneko; Karin M.L. Gaensler; Robert Blelloch展开收起
作者单位
Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, San Francisco (UCSF), San Francisco, CA, USA; Department of Urology, University of California, San Francisco (UCSF), San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA; Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan; AIVITA Biomedical, Irvine, CA, USA展开收起
PDF源文件 DOI 网页
351 天

Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement-driven immune-stromal interactions as a therapeutic target

作者
Bérénice Dugué; Pia Wanner; Mayra L. Ruiz Tejada Segura; Mohamed Saad; Lucas Greven; Katrin Götz; Carmen Schalla; Stijn Fuchs; Gerjanne Vroeg in de wei; Hélène F.E. Gleitz; Anna Katharina Galyga; Jessica Ellen Pritchard; Tobias Schlangen; Niklas Lutterbach; Salim Atakhanov; Lina Schmidt; Marie Parrens; Armelle Peyrat; Damien Luque Paz; Marie-Christine Copin; Alexandre Guy; Victor-Emmanuel Brett; Olivier Mansier; Susanne Schmitz; Paul Wanek; Bella Banjanin; Stephani Schmitz; Martina Crysandt; Marian C. Clahsen-van Groningen; Konnie M. Hebeda; Sascha Dietrich; Harald Voehringer; Matthias Meyer-Bender; Kristin Séré; Chloé James; Adam Benabid; Ivan Costa; Charles Dussiau; Rebekka K. Schneider展开收起
作者单位
University of Bordeaux, UMR1034, Inserm, Biology of Cardiovascular Diseases, 33600 Pessac, France; RWTH Aachen University, Department of Cell and Tumor Biology, Faculty of Medicine, 52074 Aachen, Germany; RWTH Aachen University, Institute for Computational Genomics, Faculty of Medicine, Aachen 52074, Germany; Erasmus Medical Center, Department of Developmental Biology, Rotterdam 3015GD, the Netherlands; Oncode Institute, Erasmus Medical Center, Rotterdam 3015GD, the Netherlands; CHU Bordeaux, Department of Pathology, 33000 Bordeaux, France; Angers University, Nantes University, CHU Angers, Inserm, CNRS, CRCI2NA, 49000 Angers, France; CHU Angers, Department of Pathology, 49000 Angers, France; CHU Bordeaux, Laboratory of Hematology, 33000 Bordeaux, France; RWTH Aachen University, Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, 52074 Aachen, Germany; University Hospital RWTH Aachen, Department of Nephrology, 52074 Aachen, Germany; Department of Pathology and Clinical Bioinformatics, Erasmus MC Transplant Institute, Rotterdam 3015GD, the Netherlands; Laboratory for Pathology (PAL), 3318 AL Dordrecht, the Netherlands; Radboud University Medical Center, Department of Pathology, 6525 GA Nijmegen, the Netherlands; University Hospital Düsseldorf, Heinrich Heine University, Department of Hematology, Oncology and Clinical Immunology, 40225 Düsseldorf, Germany; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, 69117 Heidelberg, Germany; Molecular Medicine Partnership Unit (MMPU), 69117 Heidelberg, Germany; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, 69120 Heidelberg, Germany; European Molecular Biology Laboratory, Molecular Systems Biology Unit, 69117 Heidelberg, Germany; German Cancer Research Center (DKFZ), Division of Experimental Hematology, 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany展开收起
PDF源文件 DOI 网页

FAQ

Cell Stem Cell审稿要多久?

截至2026-11-19,CrushSCI 收录了 Cell Stem Cell 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 71 天(Clinical base editing for β-hemoglobinopathies across different genetic backgrounds,2026-06-01 收稿,2026-08-11 录用),最慢一篇用了 529 天;平均 262.7 天,中位数 258 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。